Filter
816
Filtered Results: 816
Text search:
Pharmaceutical
Prices
Featured
Recommendations
69
New Publications
235
Language
Document type
No document type
411
Studies & Reports
196
Guidelines
106
Strategic & Response Plan
37
Manuals
27
Fact sheets
17
Situation Updates
9
Training Material
7
Resource Platforms
5
Brochures
1
Countries / Regions
Global
37
India
32
South Africa
22
Kenya
21
Ethiopia
20
Uganda
19
Ukraine
15
Nepal
14
Sierra Leone
14
Nigeria
14
Ghana
12
Liberia
12
Zimbabwe
11
Tanzania
11
Bangladesh
11
Zambia
11
Syria
10
Philippines
9
Africa
9
Western and Central Europe
9
Malawi
8
Latin America and the Carribbean
8
Namibia
8
Indonesia
8
Rwanda
7
Myanmar / Burma
7
Congo, Democratic Republic of
6
Senegal
5
Germany
5
Eastern Europe
5
Botswana
5
Benin
4
Cameroon
4
Cambodia
4
Venezuela
4
Lesotho
3
Albania
3
Burkina Faso
3
Mozambique
3
Haiti
3
Asia
3
South–East Asia Region
3
North America
3
Lebanon
3
Papua New Guinea
3
Eswatini/ Swaziland
3
Pakistan
3
Laos
2
Peru
2
West and Central Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Jamaica
2
Egypt
2
Sudan
2
Yemen
2
South Sudan
2
North Macedonia
1
Tajikistan
1
Thailand
1
El Salvador
1
China
1
Fiji
1
Kyrgyzstan
1
Niger
1
Afghanistan
1
Mongolia
1
Bulgaria
1
Guinea
1
Lithuania
1
Jordan
1
Western Pacific Region
1
Paraguay
1
Gabon
1
Turkmenistan
1
Denmark
1
East and Southern Africa
1
Southern Africa
1
Vietnam
1
Moldova
1
Sri Lanka
1
Russia
1
Romania
1
Palestine
1
Central African Republic
1
Mali
1
Chad
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
323
Clinical Guidelines
62
Public Health
42
Key Resources
26
Women & Child Health
20
Pharmacy & Technologies
16
Capacity Building
3
Toolboxes
Pharmacy
92
AMR
68
COVID-19
67
HIV
65
Mental Health
49
TB
25
Health Financing Toolbox
22
NCDs
21
Global Health Education
20
NTDs
16
Conflict
16
Planetary Health
15
Ebola & Marburg
10
Caregiver
7
Rapid Response
6
Refugee
5
Disability
5
Natural Hazards
3
Polio
3
Specific Hazards
2
South Sudan
1
Cholera
1
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
Recognition, Assessment and Treatment
National Clinical Guideline Number 159
A case study from Bosnia and Herzegovina Eurasian Harm Reduction Network
The case study was prepared by Samir Ibisevic, President of PROI between March and June 2016 and edited by Graham Shaw.
EHRN is grateful to all who contributed to this document, especially: Dr. Serifa Godinjak, Chairperson...
This revision to the Disaster Management Team’s (DMT) multi-sector response plan for COVID-19 is meant to align the multi-sector plan with the Department of Health’s COVID-19 Emergency Response Plan issued on 24 April 2020.
A System of Health Accounts 2011: Revised Edition provides an updated and systematic description of the financial flows related to the consumption of health care goods and services. As demands for information increase and more countries implement and institutionalise health accounts according to the...
The overall goal of the programme, to reduce the malaria morbidity and mortality by 75% (using 2012 as baseline) by the year 2020, continued to be pursued in 2014. The following areas were identified as some of the priorities for the year: Malaria Case Management under which we have Malaria in Pregn...
Sudan recorded the first COVID-19 case on 13 March 2020 and, at the beginning of July, the Federal Ministry of Health had confirmed that nearly 10,000 people had contracted the virus, including over 600 who died from the disease across the country. Although more than 70 per cent of the confirmed cas...
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
This casebook collects 64 case studies, each of which raises an important and difficult ethical issue connected with planning, reviewing, or conducting health-related research. The book’s purpose is to contribute to thoughtful analysis of these issues by researchers and members of research ethics ...
2nd edition
Constituting the second part of the World Drug Report 2022, the present booklet contains an overview of the global demand for and supply of drugs.
The first chapter of the booklet begins with the latest estimates of the number of people who use drugs, the distribution of those users by type of drug...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases and disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. Three foundational pillars will support global efforts to achieve the targets: accelerate progra...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
